Polyrizon Ltd. cotiza a 9.05 USD y tiene una capitalización bursátil de $22M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nas…
| Métrica | PLRZ | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -15.9% | -40.4% | +24.5% |
| ROA | -15.6% | -32.0% | +16.4% |
| Current Ratio | 29.03 | 2.84 | +26.19 |
| Debt / Equity | — | 0.28 | — |